机器人辅助清醒外清醒状态下丘脑底核深部脑刺激治疗帕金森病的临床结局:152例系列研究
该回顾性研究纳入152例接受机器人辅助电极植入的「清醒外」双侧丘脑底核脑深部电刺激(DBS)帕金森病患者,报告术后1年临床结局。结果显示UPDRS III评分从39改善至20.5(47%,P < .001),UPDRS总分从67.6改善至36.4(46%,P < .001),左旋多巴等效日剂量平均减少35%(P < .001),PDQ-39汇总指数平均改善7.1分;额叶与顶叶入路临床结局无显著差异。结论认为该技术疗效与传统方法相当。
要点
- 「清醒外」机器人辅助丘脑底核DBS术后1年UPDRS III改善47%,与常规技术结局相当。
- 术后左旋多巴等效日剂量平均减少35%,PDQ-39生活质量指数平均改善7.1分。
- 额叶与顶叶两种电极植入入路的临床结局无显著差异。
核心结论
- 「清醒外」机器人辅助丘脑底核DBS治疗帕金森病可获得与传统技术相当的临床结局。
研究设计与样本
- 回顾性系列研究,连续纳入152例接受「清醒外」机器人辅助丘脑底核DBS的帕金森病患者,报告术后1年结局。
主要发现
- UPDRS III评分从39改善至20.5(47%,P < .001)。
- UPDRS总分从67.6改善至36.4(46%,P < .001)。
- UPDRS II评分从18.9改善至10.5(44%,P < .001),UPDRS IV评分从7.1改善至3.6(49%,P < .001)。
- 术后左旋多巴等效日剂量平均减少35%(P < .001)。
- PDQ-39汇总指数平均改善7.1分,额叶与顶叶入路临床结局无显著差异。
临床怎么用
- 对于适合丘脑底核DBS的帕金森病患者,可考虑采用机器人辅助「清醒外」电极植入,无需微电极记录和术中测试刺激。
- 顶叶入路可作为额叶入路之外的电极植入选择,两者临床结局无显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent advances in methods used for deep brain stimulation (DBS) include subthalamic nucleus electrode implantation in the "asleep" patient without the traditional use of microelectrode recordings or intraoperative test stimulation. OBJECTIVE: To examine the clinical outcome of patients who have undergone "asleep" DBS for the treatment of Parkinson disease using robot-assisted electrode delivery. METHODS: This is a retrospective review of clinical outcomes of 152 consecutive patients. Their outcomes at 1 yr postimplantation are reported; these include Unified Parkinson's Disease Rating Scale (UPDRS) assessment, Tinetti Mobility Test, Parkinson's Disease Questionnaire (PDQ)-39 quality of life assessment, Mattis Dementia Rating Scale, Beck Depression Inventory, and Beck Anxiety. We also report on a new parietal trajectory for electrode implantation. RESULTS: A total of 152 patients underwent assessment at 1 yr. UPDRS III improved from 39 to 20.5 (47%, P < .001). The total UPDRS score improved from 67.6 to 36.4 (46%, P < .001). UPDRS II scores improved from 18.9 to 10.5 (44%, P < .001) and UPDRS IV scores improved from 7.1 to 3.6 (49%, P < .001). There was a significant reduction in levodopa equivalent daily dose after surgery (mean: 35%, P < .001). PDQ-39 summary index improved by a mean of 7.1 points. There was no significant difference found in clinical outcomes between the frontal and parietal approaches. CONCLUSION: "Asleep" robot-assisted DBS of the subthalamic nucleus demonstrates comparable outcomes with traditional techniques in the treatment of Parkinson disease.
引用
- Moran CH, Pietrzyk M, Sarangmat N, et al. Clinical Outcome of "Asleep" Deep Brain Stimulation for Parkinson Disease Using Robot-Assisted Delivery and Anatomic Targeting of the Subthalamic Nucleus: A Series of 152 Patients. Neurosurgery. 2020. PMID: 32985669. doi:10.1093/neuros/nyaa367
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。